Explore This Research Program
We are a research team composed of enthusiastic healthcare providers committed to innovation in Down syndrome research. Our team is motivated to offer research opportunities that can help maximize the life potential for all people with Down syndrome. Working collaboratively with researchers around the globe, we are dedicated to advancing our shared understanding of biological processes associated with Down syndrome. To this extent, we are proud to offer families a portfolio of research opportunities.
We are a collaborative, multidisciplinary team, serving people with Down syndrome of all ages and their families. We provide evidence-based clinical care, education, and cutting-edge research so that individuals with Down syndrome can reach their full potential.
Our passion is to provide healthcare, research, and education that contribute to a world in which all people with Down syndrome are accepted, celebrated and have the opportunity to fully realize their potential.
Longitudinal Investigation for the Enrichment of Down Syndrome Research (LIFE-DSR)
Massachusetts General Hospital’s Down Syndrome Program is pleased to introduce our new study, the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) in collaboration with LuMind IDSC. This study represents a milestone for Down syndrome research as it is the first study in LuMind’s Clinical Trails Network. LIFE-DSR is a natural history study that aims to better understand the progression of Alzheimer’s disease in those with Down syndrome.
The study will examine behavioral, cognitive, and health changes that may occur over the course of 2-3 years, with a focus on how these changes relate to the development of Alzheimer’s dementia. Alzheimer’s disease is an important topic in the DS community because by the age of 60 about 70% of those with DS will develop Alzheimer’s dementia, compared to the general population where only 10-12% of seniors develop the disease.
The goal of LIFE-DSR is to gather information in order to develop tools capable of measuring changes associated with Alzheimer’s disease in those with Down syndrome. LIFE-DSR will also collect blood samples to aid in the development of blood tests for Alzheimer’s Disease.
If you or a loved one is over the age of 25 and has Down Syndrome please consider joining this ground-breaking study. To learn more information about joining, contact Ashlee Campbell at LIFE-DSR@partners.org or (617) 726-7954.
Physical Activity Assessment in Adults with Down Syndrome
Many adult patients with Down Syndrome are overweight or obese, and physical activity which can help with weight control is therefore a health priority in individuals with Down Syndrome. Objective information about physical activity level is not typically available for individuals with Down Syndrome, however, and patient-reported or caregiver-reported physical activity estimations are not always available or accurate. All current adult patient (18 years old and over) in the Down Syndrome Program at Massachusetts General Hospital are eligible to have an objective assessment of their physical activity measured using an accelerometer. This objective physical activity assessment helps us counsel patients on healthy lifestyles and weight management, and the individual data will then be pooled to help us better understand what physical activity patterns look like in this high risk patient population.
Please contact firstname.lastname@example.org if you are interested in this project.
Phase I Clinical Trial: an investigational vaccine for treatment of Alzheimer’s disease in people with Down syndrome
It is well known that individuals with Down syndrome develop Alzheimer's at a much higher rate than the general population. This research study will test whether an investigational vaccine can affect Alzheimer's-related brain changes in Down syndrome.
Our clinical research site is looking for individuals who meet the following criteria:
- Have Down syndrome
- Are 25 to 45 years of age
- Do not have any other serious illness
- Have a caregiver/informant who can answer questions
The study is a randomized, placebo-controlled, double-blinded Phase I clinical trial. This means that study participants will be randomly given either the active investigational vaccine or a non-active placebo that looks like the active drug; neither the participant nor the study personnel at our clinic will know who is receiving which one.
The study will last 24 months, during which study participants will visit the study clinic 22 times. At each visit, participants will be asked how they are feeling, and, at some of the visits, they will undergo medical exams, memory tests, blood tests, EKG, and brain imaging scans. The investigational vaccine and research visit procedures are free of charge. Participants and their caregivers will receive $75 per visit as a study stipend.
More information on the study can be found in these Frequently Asked Questions.
For additional questions, please contact Amy Torres at email@example.com
Predicting Obstructive Sleep Apnea in People with Down Syndrome
This project seeks to develop a more efficient method of screening for obstructive sleep apnea (OSA) in individuals with Down syndrome. OSA is associated with a number of medical complications ranging from cognitive deficits to lung and heart disorders. Yet, while OSA is common among individuals with Down syndrome, the current method for diagnosing OSA—an overnight sleep study—can be uncomfortable, costly, and inconvenient for both patients and their families. Our research study will offer an opportunity to screen for OSA, while also helping us design a new tool that might help diagnose OSA in individuals with Down syndrome. For more information, please contact Dr. Skotko at firstname.lastname@example.org
Research Study of Tongue Pace Maker System (The Hypoglossal Nerve Stimulator) in children ages 10 to 21 with Down Syndrome and Severe Obstructive Sleep Apnea
This research is being conducted at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary by Drs. Hartnick, Diercks, Keamy, Kinane, Schwartz, and Skotko. As healthcare providers, we are interested in providing not only the best care for patients with Down syndrome but also in promoting research to understand and find better ways to treat their medical conditions. We are studying new ways to treat obstructive sleep apnea in children and young adults with Down syndrome who have persistent sleep disordered breathing despite prior tonsillectomy. We will be researching whether placement of an investigational surgically implanted nerve stimulator, similar to a pacemaker, is safe and effective in relieving airway obstruction during sleep. This therapy has already been tested and approved for use in adults meeting specific requirements. The purpose of this notice is to inform you about the study. Participation is voluntary. Whether or not you decide to participate will have no effect on your relationship with Massachusetts Eye and Ear Infirmary and/or Massachusetts General Hospital as a patient. If you are interested in learning more about this study, and whether or not you/your child would be an appropriate candidate, please contact the research team by calling Dr. Hartnick ator by email at Christopher_Hartnick@meei.harvard.edu.
Nutrition and Weight Management in People with Down Syndrome
Nutrition and weight management are health priorities for individuals with Down syndrome. However, quantitative data is not always available to detail the burden of poor nutrition, prevalence of overweight/obesity in the Down syndrome community or possible solutions to these problems. This poster shares novel data collected from the Massachusetts General Hospital Down Syndrome Program’s active patient pool of over 400 individuals with Down syndrome. It discusses:
- The prevalence of overweight and obesity among children and adults seen in our program, including a comparison to statistics for the general population and other individuals with intellectual or developmental disabilities.
- The natural BMI trend of a sample of our patients over a 6-month period.
- The results of surveys completed by patients on their self-identified nutrition challenges, as well as their use of mobile technology.
ELND005 Drug Trial for People with Down Syndrome Is a Success
The results are now in: The Phase 2 clinical drug trial of ELND005, sponsored by Transition Therapeutics, was a success! As many of you know, our Down Syndrome Program at Massachusetts General Hospital was one of three sites in the country selected to participate in this landmark study. We are thankful to the six adults with Down syndrome, and their caregivers, who participated at our clinic. Read a summary of the study, and learn what this might mean for your son or daughter with Down syndrome in the future.
Down Syndrome Patient Database
All current patients in the Down Syndrome Program at Massachusetts General Hospital are invited to participate in a research project to build a national registry to track the health and medical history of people with Down syndrome across their lives. Health information will be collected from existing and future medical records, so there are no extra study visits or procedures. This Down Syndrome Patient Registry is taking place at Massachusetts General Hospital, as well as other centers specializing in Down syndrome clinical care and research.
Registry Consent Form (pdf)
Meet our team
- Brian Skotko, MD, MPP
- Jeanhee Chung, MD
- Karen Donelan, ScD, EdM
- Casey Evans
- Jose Florez, MD, PhD
- Grace Hsieh, RN, PhD
- Stephen Lorenz
- Nicolas Oreskovic, MD
- Holly Parker
- Margaret Pulsifer, PhD
- Stephanie Santoro, MD
- Kay Seligsohn, PhD
- Janet Sherman, PhD
- Ashlee Campbell
- Vasiliki Patsiogiannis
Amy Torres, BS
Allareddy V, Ching N, Macklin EA, Voelz L, Weintraub G, Davidson E, Albers Prock L, Rosen D, Bruun, R, Skotko BG. (2016). Craniofacial features as assessed by lateral cephalometric measurements in children with Down syndrome. Progress in Orthodontics, 17(1):35. Article.
Sharr C, Lavigne J, Elsharkawi IMA, Ozonoff A, Baumer N, Brasington C, Cannon S, Crissman B, Davidson E, Florez JC, Kishnani P, Lombardo A, Lyerly J, McDonough ME, Schwartz A, Berrier KL, Sparks S, Stock-Guild K, Toler TL, Vellody K, Voelz L, Skotko BG. (2016). Detecting celiac disease in patients with Down syndrome. American Journal of Medical Genetics, Part A 170A: 3098-3105. Article.
Skotko, B.G., Tenenbaum, A. (2016). Down syndrome. In Rubin, I.L., Merrick, J., Greydanus, D.E., Patel, D.R. (Eds.) Health Care for People with Intellectual and Developmental Disabilities across the Lifespan. New York: Springer. Textbook.
Roberts, M., Skotko, B. (2016). Down syndrome. In Domino FJ (Ed.), www.5MinuteConsult.com, Philadelphia: Wolters Kluwer.
Anthony R. Gregg, Brian G. Skotko, Judith L. Benkendorf, Kristin G. Monaghan, Komal Bajaj, Robert G. Best, Susan Klugman, and Michael S. Watson; on behalf of the ACMG Noninvasive Prenatal Screening Work Group (2016). Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine 18(10):1056-1065. Article.
Jacobs, J., Schwartz, A., McDougle, C., Skotko, B.G. (2016). Rapid Clinical Deterioration in an Individual with Down Syndrome. American Journal of Medical Genetics Part A 170(7): 1899–1902. Article.
Diercks, G.R., Keamy D., Kinane, T.B., Skotko, B., Schwartz, A., Grealish, E., Dobrowski, J., Soose, R., Hartnick, C. (2016). Hypoglossal Nerve Stimulator Implantation in an Adolescent with Down Sydnrome and Sleep Apnea. Pediatrics 137(5):e20153663. Article. Press release.
de Graaf, G., Buckley, F., Skotko, B.G. (2016). Live births, natural losses, and elective terminations with Down syndrome in Massachusetts. Genetics in Medicine 18: 459–466. Article.
de Graaf, G., Buckley, F., Skotko, B.G. (2015). Estimates of the live births, natural losses and elective terminations with down syndrome in the United States. American Journal of Medical Genetics, Part A 167A:756–767. Article. Supplementary Materials.
Lavigne, J., Sharr, C., Ozonoff, A., Prock, L.A., Baumer, N., Brasington, C., Cannon, S., Crissman, B., Davidson, E., Florez, J.C., Kishnani, P., Lombardo, A., Lyerly, J., McCannon, J.B., McDonough, M.E., Schwartz, A., Berrier, K.L., Sparks, S., Stock-Guild, K., Toler, T.L., Vellody, K., Voelz, L., Skotko, B.G. (2015). National Down syndrome patient database: Insights from the development of a multi-center registry study. American Journal of Medical Genetics Part A 167A:2520–2526. Article.
Grieco, J., Pulsifer, M., Seligsohn, K., Skotko, B., Schwartz, A. (2015). Down Syndrome: Cognitive and Behavioral Functioning Across the Lifespan. American Journal of Medical Genetics, Part C 169C:135-149. Article.
White, Melissa (2013). Providing Breastfeeding Support in the Hospital Setting for Mothers Who Have Infants With Down Syndrome. ICAN: Infant, Child, & Adolescent Nutrition. Article.
Gregg, A.R., Gross, S.J., Best, R.G., Monaghan, K.G., Bajaj, K., Skotko, B.G., Thompson, B.H., Watson, M.S., are the Noninvasive Prenatal Screening Working Group of the American College of Medical Genetics (2013). ACMG Statement on Noninvasive Prenatal Screening for Fetal Aneuploidy. Genetics in Medicine 15(5): 395-398. Article.
Skotko, B.G., Davidson, E.J., Weintraub, G.S. (2013). Contributions of a specialty clinic for children and adolescents with Down syndrome. American Journal of Medical Genetics, Part A 161(3):430-437. Article (English). Article (Español).
Schwartz, A. (2012) The ins & outs of transition planning. (Article) (pdf)
Leach, M., Skotko, B.G. (2012). Resources available for informed prenatal decisions. (Letter to the Editor). Genetics in Medicine: 14:348-349. Letter to the Editor.
Skotko, B.G., Leach, M. (2011). Physicians need to offer up-to-date information about Down syndrome to expectant couples to inform decision-making [E-letter]. Pediatrics. October 17, 2011. Letter to the Editor.
Skotko, B.G., Levine, S.P., Goldstein, R. (2011). Having a Son or Daughter with Down Syndrome: Perspectives from Mothers and Fathers. American Journal of Medical Genetics Part A 155:2335-2347. Article. Press release.
Skotko, B.G., Levine, S.P., Goldstein, R. (2011). Having a Brother or Sister with Down Syndrome: Perspectives from Siblings. American Journal of Medical Genetics Part A: 155:2348-2359. Article. Press release.
Rosen, D., Lombardo A., Skotko, B., Davidson, E.J. (2011). Parental perceptions of sleep disturbances and sleep-disordered breathing in children with Down syndrome. Clinical Pediatrics, 50:121-125. Article.
Skotko, B. (2009). "Driving Forward." In Thicker than Water: Essays by Adult Siblings of People with Disabilities. Ed. Don Meyer. Bethesda, MD: Amazon.
Skotko, B., Kishnani, P., & Capone, G. for the Down Syndrome Diagnosis Study Group (2009). Prenatal diagnosis of Down syndrome: How best to deliver the news. American Journal of Medical Genetics, Part A,149A: 2361-2367. Article. Press release. Summary in Spanish.
Skotko, B., Capone, G., & Kishnani, P. for the Down Syndrome Diagnosis Study Group (2009). Postnatal diagnosis of Down syndrome: Synthesis of the evidence on how best to deliver the news. Pediatrics,124: e751-e758. Article. Press release. Summary in Spanish.
Skotko, B. (2009). With new prenatal testing, will babies with Down syndrome slowly disappear? Archives of Disease in Childhood, 94: 823-826. Article.
Skotko, B. & Levine S. P. (2009). Fasten Your Seatbelt: A Crash Course on Down Syndrome for Brothers and Sisters. Bethesda, MD: Woodbine House.
Florez, J. (2007). Knowledge is power. (Article).Journal of the American Medical Association, Vol 298, No.13
Skotko, B. (2007). Letter to the editor: First- and second-trimester evaluation of risk for Down syndrome. Obstetrics and Gynecology, 110: 1426. Article.
Skotko, B. (2006). Letter to the editor: A surprising postnatal diagnosis. Obstetrics and Gynecology, 108: 1297. Article.
Skotko, B., & Levine, P. (2006). What the other children are thinking: Brothers and sisters of persons with Down syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C:180-6. Article, Press release.
Skotko, B. (2006). Words matter: The importance of nondirective language in first-trimester assessments for Down syndrome. American Journal of Obstetrics and Gynecology. 195:625-26. Article.
Skotko, B. (2006). Letter to the editor: Comparing Three Screening Strategies for Combining First- and Second-Trimester Down Syndrome Markers. Obstetrics & Gynecology. 107:1170. Article.
Skotko, B., Canal, R. (2006). Continuing a Pregnancy After Receiving a Prenatal Diagnosis of Down Syndrome in Spain. Progresos en Diagnostico y Tratamiento Prenatal. 17: 189-92. Article, English version. Survey.
Skotko, B. (2005). Prenatally diagnosed Down syndrome: Mothers who continued their pregnancies evaluate their health care providers. American Journal of Obstetrics & Gynecology,192: 670-77. Article, Summary, Press Release, Survey.
Skotko, B., & Canal, R. (2004). Apoyo postnatal para madres de niños con síndrome de Down.Revista Síndrome de Down, 21: 54-71. Article.
Skotko, B. & Kidder C. (2001). Common Threads: Celebrating Life with Down Syndrome.Rochester Hills: Band of Angels Press.